Susan is an accomplished biopharma executive with 25+ years of deep operating and global leadership experience across pre-clinical entrepreneurial start-ups, mid-cap public biotech and large pharma. She is uniquely familiar with the opportunities and challenges faced by growing companies progressing from pre-clinical to clinical and onto commercial stage. Across her numerous executive leadership roles, Susan has led and concluded impactful acquisitions, product collaborations and discovery deals, both on the buy-side and sell-side and in numerous therapeutic areas. Her companies have benefitted from her track record of value creating deals, strong industry connections, capital markets experience and strategic acumen.